Background: Skin diseases such as psoriasis can profoundly influence a patient's self-
image, self-esteem, and sense of well-being. Psoriasis is a multifactorial inflammatory …

Nail involvement in psoriasis is common, and the severity of it does not always parallel the
intensity of cutaneous disease. We created a consensus group, of which the aim was to …

Objective To evaluate risankizumab, a biological therapy that inhibits interleukin 23, in
patients with active psoriatic arthritis (PsA) who have responded inadequately or are …

Objective To assess the efficacy and safety of golimumab in patients with active psoriatic
arthritis (PsA). Methods Adult patients with PsA who had at least 3 swollen and 3 tender …

The Nail Psoriasis Severity Index (NAPSI) is a numeric, reproducible, objective, simple tool
for evaluation of nail psoriasis. This scale is used to evaluate the severity of nail bed …

Background Significantly more patients with moderate‐to‐severe plaque psoriasis treated
with the interleukin (IL)‐17A inhibitor ixekizumab vs. the IL‐23p19 inhibitor guselkumab in …

The absorption of drugs into the nail unit, following topical application to the nail plate, is
highly desirable to treat nail disorders, such as onychomycosis (fungal infections of the nail) …

The purpose of this study was:(i) to examine the impact of the clinical severity, anatomical
location and treatment of psoriasis on patients' quality of life, and (ii) to investigate the effects …

Background In the phase III double-blind Efficacy and Safety Trial Evaluating the Effects of
Apremilast in Psoriasis (ESTEEM) 1 and 2, apremilast, an oral phosphodiesterase 4 …

Background Although nail psoriasis affects a marked proportion of patients with psoriasis
and causes significant psychological stress, only few epidemiological data characterizing …